Evidence map›Paper›PMID 19344675›Full record

ReviewBiochimica et biophysica acta2009

Soft materials to treat central nervous system injuries: evaluation of the suitability of non-mammalian fibrin gels.

Raivo Uibo, Ivo Laidmäe, Evelyn S Sawyer, Lisa A Flanagan, Penelope C Georges, Jessamine P Winer, Paul A Janmey

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Human cathepsins K, L, and S: Related proteases, but unique fibrinolytic activity.Biochimica et biophysica acta. General subjects · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raivo UiboImmunology Group, IGMP University of Tartu, Ravila Street 19, Tartu 51014, Estonia.
Ivo Laidmäe
Evelyn S Sawyer
Lisa A Flanagan
Penelope C Georges
Jessamine P Winer
Paul A Janmey

Funding

Mechanical control of cell growth and differentiationR01GM083272 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A · 2008 to 2011
$2.0M
Salmon fibrin gels for surgical applicationsR44NS048734 · NINDS · SEA RUN HOLDINGS, INC. · PI SAWYER, EVELYN · 2006 to 2007
$755k
NIGMS NIH HHS R01 GM083272NINDS NIH HHS 2-R44 NS048734-03NINDS NIH HHS R44 NS048734
6 · The paper itself

Abstract

Polymeric scaffolds formed from synthetic or natural materials have many applications in tissue engineering and medicine, and multiple material properties need to be optimized for specific applications. Recent studies have emphasized the importance of the scaffolds' mechanical properties to support specific cellular responses in addition to considerations of biochemical interactions, material transport, immunogenicity, and other factors that determine biocompatibility. Fibrin gels formed from purified fibrinogen and thrombin, the final two reactants in the blood coagulation cascade, have long been shown to be effective in wound healing and supporting the growth of cells in vitro and in vivo. Fibrin, even without additional growth factors or other components has potential for use in neuronal wound healing in part because of its mechanical compliance that supports the growth of neurons without activation of glial proliferation. This review summarizes issues related to the use of fibrin gels in neuronal cell contexts, with an emphasis on issues of immunogenicity, and considers the potential advantages and disadvantages of fibrin prepared from non-mammalian sources.

Indexed as

FibrinGelsAnimalsBiocompatible MaterialsBiomarkersCell Culture TechniquesCentral Nervous SystemFibrinogenHumansMaterials TestingNerve RegenerationNeuronsThrombinTissue ScaffoldsWound HealingBiocompatible MaterialsBiomarkersFibrinFibrinogenGelsThrombin

Identifiers

PMID19344675
PMCPMC2895977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.